Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Kremer AE, Mayo MJ, Hirschfield GM, Levy C, et al. Hepatology 2023 Dec 20. doi: 10.1097/HEP.0000000000000728.

Read + Share

Amedeo Smart

Independent Medical Education

Kremer AE, Mayo MJ, Hirschfield GM, Levy C, et al. Seladelpar treatment reduces interleukin-31 and pruritus in patients with primary biliary cholangitis. Hepatology 2023 Dec 20. doi: 10.1097/HEP.0000000000000728.
PMID: 38117036